ZEB1 and non-small cell lung carcinoma: In a Kras/Trp53-mutation driven mouse model of human non-small cell lung cancer (NSCLC), ZEB1 drove pro-migratory cytoskeletal processes and metastasis by downregulating the expression of miR-34a.